Phase 4 N=73 T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) - Year 1, 2009
Influenza
Primary: Number of Participants From Each Arm Who Received Influenza Vaccine Vaccine — 6; 6; 8; 6 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=216 Evaluation of Two Epoetin Alfa Dosing Strategies in Subjects With Chronic Kidney Disease Receiving Hemodialysis
Renal Insufficiency, Chronic · Anemia · Renal Dialysis
Primary: Percentage of Hemoglobin Measurements Within 10 to 11 g/dL During the Evaluation Period — 46.41; 46.02 percentage of hemoglobin measurements — p=0.46
Phase 4 N=9 Acellular Dermal Matrix in Tissue Expander Breast Reconstruction: A Prospective, Randomized, Clinical Trial Comparing SurgiMend PRS and AlloDerm RTU
Breast Cancer · Mastectomy
Primary: Complication Rates — 4; 3 Participants
Phase 4 N=139 ADAPT: Addressing Depression and Pain Together
Depression · Back Pain
Primary: Proportion Responding Initially by Treatment Arm During 14 Weeks Post Randomization — 28; 28 Participants
Phase 4 N=106 Aging Brain Changes, Executive Dysfunction and Depression
Depression
Primary: Hamilton Depression Rating Scale. — 8.09 units on a scale
Phase 4 N=9 Effectiveness of DiscontinuinG bisphosphonatEs Study: R21 Pilot Study
Osteoporosis
Primary: All Study Sites--Length of Contracting Procedures — 3.4 Months
Phase 4 N=16 Analgesic Efficacy of Intravenous Acetaminophen After Video-assisted Thoracic Surgery
Lung Tumor
Primary: Total Morphine Consumption (mg) — 34.5; 44 mg
Phase 4 N=221 Pharmacogenetic Response to Naltrexone For Alcohol Dependence
Alcohol Dependence
Primary: Clinical Response to Naltrexone, as Measured by a Reduction in the Percent Days of Heavy Drinking Days (as Defined by >5 Drinks/Day for Males; >4 for Females) During the…
Phase 4 N=112 Isotretinoin for Proliferative Vitreoretinopathy
Proliferative Vitreoretinopathy
Primary: Rate of Retinal Attachment — 50; 42 Participants
Phase 4 N=63 T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 3, 2011
Influenza
Primary: Number of Individual Twins Who Received Influenza Vaccine — 8; 10; 20; 12 Participants
Phase 4 N=86 Plasmablast Trafficking and Antibody Response in Influenza Vaccination (SLVP021 2011-2014)
Influenza
Primary: Number of Participants From Each Arm Who Received Influenza Vaccine — 42; 19; 25 Participants
Phase 4 N=37 Pioglitazone in Patients With Mood Disorders
Major Depressive Disorder · Insulin Resistance
Primary: Hamilton Depression Rating Scale at Baseline — 15.22; 13.67; 19.22; 13.25 units on a scale
Phase 4 N=500 Stepped Care for Depression and Musculoskeletal Pain
Pain · Depression
Primary: Brief Pain Inventory Interference — 5.0; 6.5; 4.6 units on a scale — p=<0.001
Phase 4 N=44 Lovaza® and Microvascular Function in Type 2 Diabetes
Hypertriglyceridemia · Diabetic Neuropathy
Primary: Efficacy Measures Are Nerve Conduction Studies, Specifically Changes in Conduction Amplitude. — 7.28; 7.14; 4.08; 3.80 uV
Phase 4 N=56 Vilazodone for Treatment of Geriatric Depression
Major Depressive Disorder
Primary: Hamilton Depression Rating Scale (HDRS) — 17.2; 16.6; 7.6; 7.5 units on a scale